ruxolitinib
incyte,novartis
['ovarian', 'gyn', 'ruxolitinib']
ruxolitinib (jaak 1/2i) added to neoadjuvant chemotherapy in #ovariancancer. the phase 1 demonstrated the combination was tolerable with expected toxicities of bone marrow and neuropathy. #asco22 #gyncsm 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc